KEI statement on GSK’s announcement of policies to expand access to patented medicines
GSK has made a major announcement of new policies to expand access to its patented medicines. A copy of the press statement is here. Continue Reading
Intellectual Property Rights
KEI Comments on Intellectual Property Protection for Artificial Intelligence Innovation, for USPTO Request for Comments
KEI Comments on Intellectual Property Protection for Artificial Intelligence Innovation, for USPTO Request for Comments Re: 84 FR 66176, Docket No. PTO-C-2019-0038 10 January 2020 1. Should a work produced by an AI algorithm or process, without the involvement of… Continue Reading
CDIP 24: KEI provides comments on the Report on the International Conference on Intellectual Property (IP) and Development
On 20 May 2019, the World Intellectual Property Organization (WIPO) convened an International Conference on Intellectual Property (IP) and Development. On 19 November 2019, at the 24th session of WIPO’s Committee on Development and Intellectual Property (CDIP), Knowledge Ecology International… Continue Reading
WHO defers South Africa’s proposal on expanding access to cancer treatments including cell and gene therapies until 2021
The 146th session of the World Health Organization’s (WHO) Executive Board will take place from 3 February 2020 to 8 February 2020 in Geneva, Switzerland. Rule 8 of the Rules of Procedure of the Executive Board of the World Health… Continue Reading
Trilateral symposium: WTO Director General Roberto Azevêdo highlights the opportunities and challenges faced in providing access to CAR T
On Thursday, 31 October 2019, the World Trade Organization (WTO) hosted the eighth trilateral symposium jointly convened by the World Health Organization (WHO) and the World Intellectual Property Organization (WIPO). The theme of this year’s symposium was ” “Cutting-Edge Health… Continue Reading
WTO TRIPS Council (October 2019): Statement of South Africa on the Transparency of R&D Costs and Pricing of Medicines and Health Technology
On Friday, 18 October 2019, South Africa delivered the following statement at the WTO TRIPS Council on transparency of R&D Costs and Pricing of Medicines and Health Technology. Intellectual Property and the Public Interest: R&D Costs and Pricing of Medicines… Continue Reading
SCCR 39: KEI statement on copyright related to the digital environment
On Friday, 25 October 2019, Knowledge Ecology International delivered the following statement on copyright related to the digital environment. Given the challenges of obtaining economic data, perhaps the SCCR could focus more on transparency. 1. Standards for transparency could be… Continue Reading
SCCR 39
SCCR 39: Opening statement of Knowledge Ecology International
On Monday, 21 October 2019, Knowledge Ecology International delivered the following opening statement at the 39th session of the WIPO Standing Committee on Copyright and Related Rights (SCCR 39). The discussions on limitations and exceptions, and the studies commissioned by… Continue Reading
WTO TRIPS Council: Submission of South Africa on R&D Costs and Pricing of Medicines and Health Technologies
On Friday, 4 October 2019, the World Trade Organization (WTO) published a submission by the Republic of South Africa on “R&D Costs and Pricing of Medicines and Health Technologies” (IP/C/W/659). In this paper, South Africa requested the WTO TRIPS Council… Continue Reading
WIPO General Assembly 2019: KEI statement on the Report on the SCP
On Thursday, 3 October 2019, Knowledge Ecology International delivered the following statement on Agenda item 16, Report on the SCP. As part of the WIPO Secretariat’s review of existing research on patents and access to medical products and health technologies,… Continue Reading